Tempus AI, Inc. (TEM)

TEM Balance Sheet

Assets, liabilities, and equity analysis

TEM Quarterly Balance Sheet (USD)

Quarterly Report	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024	09/30/2024	06/30/2024
Total Current Assets	1.054B	1.054B	1.167B	1.147B	644.201M	573.970M	667.603M	679.412M	671.366M
Cash & Cash Equivalents	521.170M	521.170M	604.787M	655.918M	186.310M	151.603M	340.954M	388.006M	478.811M
Short-Term Investments	117.902M	117.902M	150.211M	103.720M	104.996M	67.183M	107.309M	78.317M	11.255M
Cash & Short-Term Investments	639.072M	639.072M	754.998M	759.638M	291.306M	218.786M	448.263M	466.323M	490.066M
Accounts Receivable	308.599M	308.599M	311.170M	288.626M	268.819M	262.613M	154.819M	145.616M	118.106M
Inventory	51.831M	51.831M	51.724M	54.976M	47.600M	50.485M	38.386M	36.138M	32.690M
Total Assets	2.135B	2.135B	2.275B	2.281B	1.625B	1.543B	926.116M	971.728M	864.611M
Property, Plant & Equipment	150.899M	150.899M	153.652M	157.611M	131.214M	133.162M	72.818M	73.533M	74.533M
Goodwill	470.169M	470.169M	470.211M	465.140M	325.793M	325.774M	73.343M	73.365M	73.345M
Intangible Assets	330.587M	330.587M	355.253M	372.876M	387.564M	399.544M	11.716M	14.289M	16.252M
Long-Term Investments	20.530M	20.530M	21.111M	98.998M	95.718M	94.153M	91.450M	103.699M	0.00
Total Current Liabilities	317.956M	317.956M	372.388M	350.028M	418.160M	336.470M	291.070M	252.620M	181.564M
Accounts Payable	41.023M	41.023M	81.994M	59.553M	79.323M	88.732M	53.804M	49.027M	28.646M
Short-Term Debt	12.639M	12.639M	13.355M	12.417M	0.00	0.00	0.00	0.00	0.00
Total Liabilities	1.719B	1.719B	1.784B	1.774B	1.316B	1.217B	869.777M	918.000M	766.360M
Long-Term Debt	801.990M	801.990M	802.350M	1.246B	798.005M	800.764M	435.436M	438.987M	442.501M
Total Debt	814.629M	814.629M	815.705M	1.336B	853.252M	857.751M	468.094M	471.545M	475.567M
Net Debt (Cash)	293.459M	293.459M	210.918M	679.903M	666.942M	706.148M	127.140M	83.539M	-3.244M
Total Shareholders' Equity	416.405M	416.405M	491.326M	507.824M	309.562M	326.194M	56.339M	53.728M	98.251M
Common Stock	0.00	0.00	0.00	18K	18K	18K	17K	16K	16K
Retained Earnings	0.00	0.00	0.00	-2.342B	-2.262B	-2.219B	-2.151B	-2.138B	-2.062B
Current Ratio	3.31	3.31	3.13	3.28	1.54	1.71	2.29	2.69	3.70
Debt to Equity Ratio	1.96	1.96	1.66	2.63	2.76	2.63	8.31	8.78	4.84

TEM Annual Balance Sheet (USD)

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Total Current Assets	1.167B	667.603M	350.331M	438.629M	403.988M	649.730M	276.232M
Cash & Cash Equivalents	604.787M	340.954M	165.767M	302.938M	277.686M	513.436M	227.599M
Short-Term Investments	150.211M	107.309M	31.807M	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	754.998M	448.263M	197.574M	302.938M	277.686M	513.436M	227.599M
Accounts Receivable	311.170M	154.819M	94.462M	88.684M	82.244M	87.259M	31.888M
Inventory	51.724M	38.386M	28.845M	22.282M	22.908M	37.557M	8.279M
Total Assets	2.275B	926.116M	564.052M	631.364M	531.354M	751.918M	370.171M
Property, Plant & Equipment	153.652M	72.818M	82.211M	67.786M	35.395M	38.435M	36.065M
Goodwill	470.211M	73.343M	73.354M	53.100M	15.985M	15.992M	15.986M
Intangible Assets	355.253M	11.716M	21.916M	37.278M	37.286M	44.459M	41.330M
Long-Term Investments	21.111M	91.450M	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	372.388M	291.070M	232.627M	174.239M	114.806M	101.382M	43.733M
Accounts Payable	81.994M	53.804M	54.421M	45.987M	33.753M	53.571M	13.415M
Short-Term Debt	13.355M	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	1.784B	869.777M	1.946B	1.760B	1.339B	1.265B	624.586M
Long-Term Debt	802.350M	435.436M	449.665M	389.546M	238.236M	250.000M	0.00
Total Debt	815.705M	468.094M	488.142M	433.029M	238.946M	251.447M	2.592M
Net Debt (Cash)	210.918M	127.140M	322.375M	130.091M	-38.740M	-261.989M	-225.007M
Total Shareholders' Equity	491.326M	56.339M	-1.382B	-1.129B	-807.491M	-512.984M	-254.415M
Common Stock	0.00	17K	6K	6K	6K	6K	6K
Retained Earnings	0.00	-2.151B	-1.397B	-1.138B	-807.486M	-512.989M	-257.853M
Current Ratio	3.13	2.29	1.51	2.52	3.52	6.41	6.32
Debt to Equity Ratio	1.66	8.31	-0.35	-0.38	-0.30	-0.49	-0.01

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Tempus AI, Inc.

Tempus AI, Inc. functions as a pioneering health technology enterprise. It specializes in delivering advanced diagnostic services, including cutting-edge genomic sequencing, PCR analysis, molecular genotyping, and various other anatomical and molecular pathology assessments. These vital services are provided to a diverse clientele, including medical practitioners, pharmaceutical companies, biotechnology innovators, scientific researchers, and other collaborating entities. The company offers "Insights," a licensed repository of de-identified clinical, molecular, and imaging data, complemented by a comprehensive suite of analytical and cloud-based computing services, primarily aimed at pharmaceutical and biotechnology firms. Additionally, its "Trials" program facilitates clinical trial matching services specifically for pharmaceutical companies. Tempus AI also manages several other platforms: "Next"; "Algos," a collection of algorithm-driven tests focused on oncology; "Hub," a versatile desktop and mobile application for ordering, managing, and receiving test results for patients; and "Lens," a dedicated portal enabling researchers and scientists to discover, access, and analyze the extensive Tempus dataset. Further demonstrating its commitment to innovation, Tempus AI has formed strategic alliances with AstraZeneca and Pathos AI, Inc. for the co-development of oncological therapeutic initiatives. Established in 2015, the company was initially known as Tempus Labs, Inc. before officially rebranding to Tempus AI, Inc. in January 2023. Its operations are based out of Chicago, Illinois.

Chicago, IL

2,400 employees

www.tempus.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Eric Lefkofsky

View full financials